Stocks & ETFs

Medicines Co. Price Target Boosted by Chardan to $85 From $80, Buy Rating Maintained

Medicines Co. Price Target Boosted by Chardan to $85 From $80, Buy Rating Maintained

August 30, 2017 at 2:10 pm 0 comments

Medicines Co. (MDCO) received a price-target boost Tuesday from Chardan Capital Markets following the biopharmaceutical company’s Monday release with partner Alnylam Pharmaceuticals (ALNY) of an encouraging update on their phase 2 trial of inclisiran in hypercholesterolemia. The new price target from Chardan is $85 per share, up from $80 and well above the stock’s Monday closing price of $37.72. ChardanRead More

Pacira Pharmaceuticals Upgraded by Janney

Pacira Pharmaceuticals Upgraded by Janney

August 21, 2017 at 11:58 am 0 comments

Pacira Pharmaceuticals received an investment-rating upgrade Monday to neutral from sell from Janney Montgomery Scott as the firm noted a nearly 30% decline in the pharmaceutical company’s stock over the past month has brought it near the firm’s fair-value estimate of $36 each. Janney said its sell rating on the stock had been based on the belief it was “wayRead More

Rada Electronics Industries Awarded Contract

Rada Electronics Industries Awarded Contract

August 16, 2017 at 10:26 am 0 comments

Rada Electronics Industries said it has received a strategic first order for dozens of Multi-Mission Hemispheric Radars (MHR) for more than $8 million. The radars will be used by the U.S. military, providing it with air surveillance with emphasis on counter-unmanned aerial vehicles (UAV). The radars are expected to be fielded for operational use soon after delivery, which will takeRead More

Eversource Energy Gets Positive Regulatory Decision on Project

Eversource Energy Gets Positive Regulatory Decision on Project

August 11, 2017 at 12:20 pm 0 comments

Eversource Energy said the U.S. Department of Energy has issued the final environmental Impact statement for the Northern Pass hydroelectric transmission project. The company said the DoE concluded that the proposed Northern Pass route is the “preferred alternative,” that the project provides substantial benefits, and that it will result in only minimal impact, Eversource said. Eversources said it expects toRead More

Zoetis Meets Q2 Street Views on EPS and Revenues

Zoetis Meets Q2 Street Views on EPS and Revenues

August 8, 2017 at 12:03 pm 0 comments

Zoetis, a purveyor of medicines for animals, Tuesday reported Q2 earnings and revenues in line with Street views. Zoetis reported Q2 adjusted EPS of $0.53, in line with Street views as compiled by Capital IQ, and above the $0.49 reported a year earlier. The company reported revenues of $1.27 billion, also in line with Street views, and above the $1.21Read More

Digital Realty Trust Prices Senior Notes

Digital Realty Trust Prices Senior Notes

August 3, 2017 at 12:03 pm 0 comments

Digital Realty Trust (DLR), a real estate investment trust, has priced an underwritten public offering of $350 million of 2.750% notes due 2023 and $1.0 billion of 3.700% notes due 2027. The notes will be senior unsecured obligations of the operating partnership and will be fully and unconditionally guaranteed by the company. The 2023 notes were issued at 99.930% ofRead More

Dana Tops Estimates On EPS and Revenues

Dana Tops Estimates On EPS and Revenues

July 31, 2017 at 11:41 am 0 comments

Dana, a service provider for vehicles and machinery, reported Q2 adjusted earnings of $0.68, up from $0.53 in the same period a year ago and topping the estimate of $0.52 from analysts polled by CapIQ. Total revenues of $1.84 billion were up from $1.55 billion in the same period a year ago and exceeded the Street projection of $1.67 billion.Read More